Jazz Pharmaceuticals plc
JAZZ
$244.96
-$0.89-0.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 126.83% | 416.86% | 6.45% | 16.91% | -526.24% |
| Total Depreciation and Amortization | 2.93% | 10.07% | 6.38% | 7.88% | 6.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -85.61% | -177.76% | -55.76% | -291.54% | 3,516.27% |
| Change in Net Operating Assets | 71.13% | -104.20% | 9.00% | 595.98% | -1,119.88% |
| Cash from Operations | 368.13% | -5.03% | -9.05% | 19.03% | -73.20% |
| Capital Expenditure | -40.31% | -41.73% | -25.91% | -40.67% | -81.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 62.17% | 192.07% | -113.11% | -239.02% | 192.00% |
| Cash from Investing | 155.37% | 172.84% | -92.54% | -253.12% | -149.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12,987.01% | 98.97% | 0.00% | 98.67% | 0.65% |
| Issuance of Common Stock | 116.19% | 186.09% | 826.34% | 4,211.76% | -4.02% |
| Repurchase of Common Stock | 92.53% | -54.17% | 50.16% | 97.49% | 22.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -699.44% | 90.35% | 1,011.66% | -104.39% | 22.77% |
| Foreign Exchange rate Adjustments | -113.04% | -123.53% | 101.44% | -93.39% | 706.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.59% | 182.11% | -66.19% | -84.21% | -667.27% |